| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Flynn Patrick John is a Director at NRX Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 5 buys and 0 sells.
Estimated insider holdings value: $5K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 28, 2022 | NRXP Nrx Pharmaceuticals, Inc. | Director | Buy | 11,750 | $1.25 | $14,662.50 | +8.1% | -19.2% | -73.4% |